FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

This article examines the fallout from large staffing cuts at the U.S. Food and Drug Administration (FDA) tied to the Trump administration’s Department of Government Efficiency (DOGE) initiative and the agency’s ongoing struggle to rebuild. According to reporting by STAT, roughly 3,500 FDA employees were dismissed, including experienced scientists, reviewers, and technical staff whose work supports drug approvals, food safety oversight, and medical product regulation.

Certara scientist Kevin Snyder’s perspective is woven throughout the piece, including how his current role at Certara has allowed him to make a bigger impact on public health. The article also touches on his experience building an FDA database, how funding changes affected his work, and the agency’s limited direction and involvement around animal testing initiatives